In this webinar, we will explore the available literature data reporting the outcomes of moderate hypofractionation and extreme hypofractionation applied in the setting of locally advanced non-small cell lung cancer.

The educational aims of the webinar are the following:

1- provide an overview about the current state-of-the-art of radiotherapy for locally advanced non-small cell lung cancer

2- discuss and evaluate the role of moderate hypofractionation either in the sequential or concurrent chemoradiation setting

3- assess the potential role of extreme hypofractionation in this challenging scenario.